SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-028523
Filing Date
2021-07-15
Accepted
2021-07-15 18:21:36
Documents
1
Period of Report
2021-07-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1488
  Complete submission text file 0000899243-21-028523.txt   2841
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Issuer) CIK: 0001783328 (see all company filings)

IRS No.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O TSCAN THERAPEUTICS, INC. 830 WINTER STREET WALTHAM MA 02451
Business Address
Gruia Gabriela (Reporting) CIK: 0001860326 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40603 | Film No.: 211093667